News
Media
Puzzler
Publications
CME/CE
Resources
Conferences
Partnerships
Subscribe
Editorial

|Articles|October 1, 2000

Updates

Volunteering overseas, Advocate extraordinaire, Another salvo in the co-sleeping wars, The high cost of hazing; Eye on Washington

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Related Content

Dexcom Stelo cleared as first OTC continuous glucose monitor for children Credit: US Food and Drug Administration

Dexcom Stelo cleared as first OTC continuous glucose monitor for children

ByPatrick Campbell

June 12th 2026

Weekly review: Mental health concerns, FDA approvals, and more

Weekly review: Mental health concerns, FDA approvals, and more

ByMorgan Ebert, Executive Editor

June 12th 2026

Jeffrey Temple, PhD, discusses new Surgeon General Advisory on screen time use in youth

Jeffrey Temple, PhD, discusses new Surgeon General Advisory on screen time use in youth

ByJeffrey R. Temple, PhD

June 12th 2026

Immune endotype linked to poorer recovery in pediatric sepsis, organ failure | Image Credit: © Zerbor - stock.adobe.com

Immune endotype linked to poorer recovery in pediatric sepsis, organ failure

ByMorgan Ebert, Executive Editor

June 12th 2026

Handheld optical device detects necrotizing enterocolitis in premature infants before radiographic signs appear | Image Credit: © Rattanachat - stock.adobe.com

Handheld optical device detects necrotizing enterocolitis in premature infants before radiographic signs appear

ByMorgan Ebert, Executive Editor

June 11th 2026

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Trending on Contemporary Pediatrics

Handheld optical device detects necrotizing enterocolitis in premature infants before radiographic signs appear

ADA 2026 data highlight pediatric outcomes and treatment satisfaction with Afrezza

Dexcom Stelo cleared as first OTC continuous glucose monitor for children

Weekly review: Mental health concerns, FDA approvals, and more

FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19